alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2020380EN.01001101.xml

| 11.11.2020 | EN | Official Journal of the European Union | C 380/11 |
| --- | --- | --- | --- |

11.11.2020

EN

Official Journal of the European Union

C 380/11

---

Prior notification of a concentration

(Case M.9995 — Permira/Neuraxpharm)

(Text with EEA relevance)

(2020/C 380/10)

1.

This notification concerns the following undertakings:

| — | Permira Holdings Limited (‘Permira’, Guernesy), and |
| --- | --- |

—

Permira Holdings Limited (‘Permira’, Guernesy), and

| — | Neuraxpharm Midco S.C.A. (‘Neuraxpharm’, Luxembourg). |
| --- | --- |

—

Neuraxpharm Midco S.C.A. (‘Neuraxpharm’, Luxembourg).

Permira acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Neuraxpharm.

The concentration is accomplished by way of purchase of shares.

2.

| — | for ‘Permira’: a European private equity firm which makes long-term investments in companies active in a wide variety of sectors that have potential for growth and development. |
| --- | --- |

—

for ‘Permira’: a European private equity firm which makes long-term investments in companies active in a wide variety of sectors that have potential for growth and development.

| — | for Neuraxpharm: a European specialty pharmaceutical company focused on the treatment of central nervous system disorders. In addition, Neuraxpharm, via its subsidiaries, provides contract development and manufacturing organization services for finished dosage forms and active pharmaceutical ingredients, both to the group companies and to third parties. |
| --- | --- |

—

for Neuraxpharm: a European specialty pharmaceutical company focused on the treatment of central nervous system disorders. In addition, Neuraxpharm, via its subsidiaries, provides contract development and manufacturing organization services for finished dosage forms and active pharmaceutical ingredients, both to the group companies and to third parties.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9995 — Permira/Neuraxpharm

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

### Correction

In notice document E9-23375 beginning on page 49892 in the issue of Tuesday, September 29, 2009, make the following correction:

On page 49893, in the first column, immediately following the signature block, three photo pages did not appear. The photo pages are printed below in their entirety.
      ( print page 51879)          ( print page 51880)          ( print page 51881)          ( print page 51882)    

[FR Doc. Z9-23375 Filed 10-7-09; 8:45 am]

BILLING CODE 1301-00-D
# C_2020338EN.01000101.xml

| 12.10.2020 | EN | Official Journal of the European Union | C 338/1 |
| --- | --- | --- | --- |

12.10.2020

EN

Official Journal of the European Union

C 338/1

---

Non-opposition to a notified concentration

(Case M.9517 — Mylan/Upjohn)

(Text with EEA relevance)

(2020/C 338/01)

On 22 April 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9517. EUR-Lex is the on-line access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9517. EUR-Lex is the on-line access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Christopher BEAVER, Appellant, v. Jennifer R. BEAVER, Appellee.

Case No. 5D18-1004

District Court of Appeal of Florida, Fifth District.

Decision filed August 28, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
P.1 

OAR Box 1787 

Prepped by Ollie Stewart 

Document Number: 

18) II-B-3 

Docket Number: 

A-90-37 

Printed 11/4/200810:22:18 AM Sheet 18 of 147 
P.2 

A-qo-37 

IT-B-3 

* **•** \ UN1TE0 STATES ENVIRONMENTAL PROTECTION AGENCY 

^SSQyll WASHINGTON, D.C. 20440 <i ••twrt' 

M I 9 «_ , 

11 V/ S !; -, 

• Sir- :•! j 

MEMORANDUM ,THE W^INISTRATOR 

TO: William G. Rosenberg J ^ , ., 

SUBJECT: Top-Down BACT 

As you know, we have been exploring ways to improve the Best Available Control 

Technology process to ensure that cost-effective technology determinations are made. 

Getting input from parties who are interested and affected - pulp and paper, independent 

power, electric utilities, natural gas, environmentalists and state and local environmental 

agency representatives — has been a very useful, timely and informative process. 

After considering all the information that was presented to me, I have decided that the 

current top-down BACT policy is working reasonably well and does not warrant immediate 

action. Nevertheless, BACT improvements should be identified and can best be considered 

as part of our ongoing comprehensive review of the New Source Review program. It was in 

this review of the New Source program that larger concerns were expressed, and thus in 

reconsidering the overall process we are likely to find the greatest opportunities to reduce 

transaction costs while maintaining environmental benefits. 

I understand that your Office has already conducted one roundtable meeting with the 

many parties concerned with improving the New Source Review process. I have decided that 

your office should explore the possibility of convening a formal regulatory negotiation, 

involving all the relevant parties. The reg-neg process, which OAR used so effectively on 

past clean air rulemakings, looks like an effective means to reconcile the divergent views of 

parties affected by BACT and other New Source Review requirements. Since a new 

Administrator will shortly be in office, I ask that the air staff conduct the requisite 

consultations and prepare the materials necessary to move forward, looking for an early 

chance to brief the incoming team. 

I appreciate your efforts to improve the BACT process, and am confident that this 

decision to consider BACT as one element of an overall effort to improve anjl^treamline the 

New Source Performance Review is the best course,of action for industry, /he public, states, 

and the environment. 

Ptintad on Recycled Paper
## Breadcrumb

-  Home 

# Explore Search: Cascading Hazards

Filters

              - science_education(1)
              - science_faqs(11)
              - science_science(46)
              - products_data(5)
              - products_maps(3)
              - products_publications(63)
              - products_web_tools(1)
              - multimedia_audio(6)
              - multimedia_audio-141766(6)
              - multimedia_before_after(1)
              - multimedia_image(127)
              - multimedia_image-141771(119)
              - multimedia_image-141773(1)
              - multimedia_image-141774(1)
              - (-)multimedia_image-141775(6)
              - multimedia_slideshow(1)
              - multimedia_video(112)
              - multimedia_video-149194(43)
              - multimedia_video-149195(29)
              - multimedia_video-149196(1)
              - multimedia_video-149197(2)
              - multimedia_video-149198(31)
              - multimedia_video-149225(2)
              - multimedia_webcam(1)
              - multimedia_webcam-141786(1)
              - news_news-149245(5)
              - news_news-149248(1)
              - news_news-149250(3)
              - news_other_news(9)
              - connect_locations(1)
              - connect_social_media(1)
              - connect_staff_profiles(32)
              - other_basic-42(5)

## By Location

              - california(1)
              - hawaii(1)
              - oregon(2)
              - washington(2)

## By Year

Charts or Graphs        December 31, 2008        Eruptions in the Cascade Range during the past 4000 years. USGS GIP 64

Charts or Graphs        December 31, 2013        Map showing one-year probability of accumulation of 1 centimeter

Charts or Graphs        December 31, 2004        Physiographic Cascadia

Charts or Graphs        May 1, 2001        Interferogram image made from InSAR monitoring, showing 1995-2001 ground uplift in the Three Sisters.

Charts or Graphs        September 1, 2014        Map of June 27th flow in Kīlauea's ERZ

Charts or Graphs        November 28, 2012        Crater Lake combined digital elevation and bathymetric map showing ...
Stevie Dean SMITH, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-1712

District Court of Appeal of Florida, Fifth District.

Decision filed August 28, 2018 Rehearing Denied October 3, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
## Breadcrumb

-  Home 

# Explore Search: Death Valley;Salt Creek

Filters

              - products_publications(2)

## By Location

              - california(2)

## By Year

publication        January 1, 2012        Evaluation of otoliths Salt Creek pupfish (Cyprinodon salinus salinus) for use in analyses of age and growth

publication        October 6, 2012        Coarse-scale movement patterns of a small-bodied fish inhabiting a desert stream
## Breadcrumb

-  Home 

# Explore Search: Crop water productivity

Filters

              - products_publications(1)

## By Location

              - alabama(1)
              - arizona(5)
              - arkansas(2)
              - california(16)
              - colorado(1)
              - florida(1)
              - hawaii(3)
              - idaho(1)
              - illinois(2)
              - indiana(1)
              - iowa(5)
              - kansas(2)
              - louisiana(2)
              - minnesota(1)
              - mississippi(5)
              - (-)missouri(1)
              - nebraska(1)
              - new mexico(2)
              - ohio(1)
              - oklahoma(2)
              - oregon(2)
              - puerto rico(1)
              - south dakota(25)
              - tennessee(1)
              - texas(3)
              - u.s. virgin islands(1)
              - virginia(1)
              - washington(1)

## By Year

publication        January 1, 2012        Complexity of human and ecosystem interactions in an agricultural landscape
Exhibit
32


CERTIFICATION PURSUANT TO 18 USC
SECTION 1350
 
 
  CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO SECTION 906 OF THE
 SARBANES-OXLEY ACT OF
2002
   In
connection with the Quarterly Report of Turner Valley Oil & Gas, Inc.,
a Nevada corporation (the "Company"), on Form 10-Q for the quarter
ended September 30, 2008 as filed with the Securities and Exchange
Commission (the "Report"), I, Kulwant Sandher, President/CFO of the Company,
certify, pursuant to 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350),
that to my knowledge:
  (1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
  (2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
  Dated:
November 14, 2008
   /s/ Kulwant
Sandher
 Kulwant
Sandher
 President
/ CFO
 
 
  CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO SECTION 906 OF THE
 SARBANES-OXLEY ACT OF
2002
   In
connection with the Quarterly Report of Turner Valley Oil & Gas, Inc.,
a Nevada corporation (the "Company"), on Form 10-Q for the quarter
ended September 30, 2008 as filed with the Securities and Exchange
Commission (the "Report"), I, Christopher Paton-Gay, CEO of the Company,
certify, pursuant to 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350),
that to my knowledge:
  (1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
  (2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
  Dated:
November 14, 2008
   /s/ Christopher
Paton-Gay
 Christopher
Paton-Gay
 Chairman
/ CEO
James H. SPICER, Appellant, v. STATE of Florida, Appellee.

No. 1D17-1799

District Court of Appeal of Florida, First District.

September 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
**EXHIBIT
      32.1**








**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the quarterly report of Interactive Therapeutics, Inc. (the
      “Company”) on Form 10-QSB for the quarter ended June 30, 2005, as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, J.
      Leonard Ivins, Principal Executive Officer of the Company, certify, pursuant
      to
      18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that to the best of my knowledge:





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.











_ /s/
      J.
      Leonard Ivins ________________


J.
      Leonard Ivins,


Principal
      Executive Officer and


Principal
      Financial and Accounting Officer


August
      15, 2005








A
      signed
      original of this written statement required by Section 906 has been provided
      to
      Interactive Therapeutics, Inc. and will be retained by Interactive Therapeutics,
      Inc. and furnished to the Securities and Exchange Commission or its staff upon
      request.
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5481 Introduced in House (IH)]

<DOC>

114th CONGRESS
  2d Session
                                H. R. 5481

To amend the Higher Education Act of 1965 to authorize institutions of 
 higher education to provide additional loan counseling, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 14, 2016

  Mr. Salmon (for himself and Mr. Grothman) introduced the following 
    bill; which was referred to the Committee on Education and the 
                               Workforce

_______________________________________________________________________

                                 A BILL

 
To amend the Higher Education Act of 1965 to authorize institutions of 
 higher education to provide additional loan counseling, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensure Responsible Borrowing Act''.

SEC. 2. ENTRANCE COUNSELING FOR BORROWERS.

    Section 485(l) of the Higher Education Act of 1965 (20 U.S.C. 
1092(l)) is amended by adding at the end the following:
            ``(3) Additional counseling.--In addition to the entrance 
        counseling under paragraph (1), an eligible institution may 
        require any borrower, at or prior to the time of a disbursement 
        to the borrower of a loan made under part D (other than a 
        Federal Direct Consolidation Loan or a Federal Direct PLUS loan 
        made on behalf of a student), to receive the information 
        described in paragraph (2) with respect to such loan, or any 
        other financial counseling, including financial literacy 
        counseling.
            ``(4) Annual loan acceptance.--Prior to making the first 
        disbursement of a loan made under part D (other than a Federal 
        Direct Consolidation Loan) to a borrower for an award year, an 
        eligible institution, shall ensure that after receiving the 
        applicable counseling under paragraph (2) or (3), the borrower 
        accepts the loan for such award year by--
                    ``(A) signing the master promissory note for the 
                loan;
                    ``(B) signing and returning to the institution a 
                separate written statement that affirmatively states 
                that the borrower accepts the loan; or
                    ``(C) electronically signing an electronic version 
                of the statement described in subparagraph (B).''.
                                 <all>
```
Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (18 U.S.C. Section 1350)

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (the
Report) of UTEK Corporation (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Clifford M. Gross, the Chief Executive Officer of the Registrant, hereby certify, to the best of my
knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Registrant.



|                               |  | 
|------------------------------ |  | 
|/s/ Clifford M. Gross          |  | 
|Name: Clifford M. Gross, Ph.D. |  | 
|Date: May 4, 2007              |  |
Caddis Insurance Services, LLC 

Arbitrarion and Consulrin g Services 

February 7, 2012 

Docket Management Facility 

U.S. Department of Transportation 

1200 New Jersey Avenue SE 

West Building Ground Floor, Room W12-140 

Washington, DC 20590 

Uil fre '3 P 5 b 

RE: Sun Country Slot Exemption, Docket Number FAA-2012-0089 

This letter is being written in support of Sun Country Airlines' request for an exemption from the slot 

limit for Ronald Reagan Washington National Airport (DCA). The proposed slots would replace two slot 

exemptions under DOT Order 2010-12-16 that were awarded to Sun Country, for service from 

Minneapolis (MSP) and Lansing, Michigan (LAN) to DCA. 

Due to a January 6, 2012 US Court of Appeals ruling, the DOT order was vacated and Sun Country will 

lose its existing service between Lansing's Capital Region International Airport and DCA. Sun Country's 

request is for one daily slot during each of the 1000 and 1100 hours. This would enable Sun Country to 

continue operating its present services and avoid the injurious result of the Court of Appeal's order. 

I am the retired CEO of Michigan Millers Mutual Insurance Company and presently run a small business 

in the Lansing, Michigan area. I have been very active in our community, serving of numerous civic and 

charitable boards. I can readily attest that the negative Impact of the Court's ruling will be significant. 

The community welcomed this service from Michigan's capital city to the nation's capital after years of 

efforts to find direct service without success. The end result was significant utilization of this service by 

the region. This is the only direct service to Washington DC in our state outside of Detroit. 

This service is essential to the continued economic growth of the Greater Lansing Region and it is crucial 

-that the FAA take the steps needed to allow.continued service...I.urge y_gyx.imniediate approval ofjhis 

exemption request. 

Sincerely, 

^At^^^-^^m^^i^c^^ 

Richard A. Rasmussen 

Richard A. Raimusscn, CPCU, ARc 

ARIAS-US Certified Arl.irnmr 

152W Club Course Df. 

Bath, M l 'iSSnS 

I'hone: 5)7-282-7711 

Email: rr.isimissen06@v.ihno.c<">in
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 1 of 6
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 2 of 6
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 3 of 6
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 4 of 6
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 5 of 6
Case 19-01298-MAM Doc 474-24 Filed 10/22/20 Page 6 of 6